Personalized addiction treatment: How close are we?

Alcohol and Alcoholism

Volumn 46, Issue 3, 2011, Pages 231-232

  Oslin, David ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; BIOLOGICAL MARKER; MU OPIATE RECEPTOR; NALTREXONE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; COGNITION; DRUG EFFICACY; GENE FREQUENCY; HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PSYCHOTHERAPY; SOCIAL SUPPORT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ALCOHOLISM; BEHAVIOR, ADDICTIVE; BIOLOGICAL MARKERS; HUMANS; INDIVIDUALIZED MEDICINE; RECEPTORS, OPIOID, MU;

EID: 79955413650     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agr030     Document Type: Article

References (10)

1. Anton R. (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65:135-44.
2. Childress AR, Ehrman RN, Wang Z, Li Y et al. (2008) Prelude to passion: limbic activation by "unseen" drug and sexual cues. PLoS One 3:e1506.
3. Evans WE, Relling MV. (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487-91.
4. Franklin TR, Wang Z, Wang J, Sciortino N et al. (2007) Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 32:2301-9.
5. Gelernter J, Gueorguieva R, Kranzler HR, Zhang H et al. (2007) Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcoholism: Clin Exp Res 31:555-63.
6. Laaksonen E, Lahti J, Sinclair JD, Heinala P et al. (2011) Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference. Alcohol Alcohol 46:308-11.
7. Myrick H, Anton RF, Li X, Henderson S et al. (2004) Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology 29:393-402.
8. Oslin D, Berrettini W, Kranzler H, Pettinati H et al. (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546-52.
9. Plebani JG, Oslin DW et al. (in press) Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study. Am J Addict.
10. Ray LA, Oslin DW. (2009) Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study. Drug Alcohol Depend 105:256-8.